secwatch.observer — SEC 8-K summary
======================================

Issuer:     Keenova Therapeutics plc (—)
CIK:        0001567892
Form:       8-K
Filed at:   2023-06-20T23:59:59+00:00
Accession:  0001104659-23-072532
Event type: other_material
Sentiment:  negative
Materiality: 1.00
Item codes: 2.04
LLM model:  deepseek-v4-flash:cloud@v2

Mallinckrodt misses $17M interest payment, default risk looms
-------------------------------------------------------------

- Company skipped ~$17M interest due June 20 on $1.728B first lien term loans.
- Non-payment triggers 5-business-day grace period; event of default if uncured.
- Default could accelerate term loans and cross-default ABL facility and opioid settlement.
- Board evaluating capital options including possible bankruptcy filing.
- Stakeholder discussions ongoing; no assurance of outcome.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1567892/000110465923072532/0001104659-23-072532-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1567892/000110465923072532/tm2319092d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-23-072532

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer